Kg&L Capital Management,Llc Gilead Sciences, Inc. Transaction History

Kg&L Capital Management,Llc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$60.0 - $68.46 $290,520 - $331,483	-4,842 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $1,472 - $1,678	26 Added 0.54%	4,842 $282,000
Q3 2020 Oct 13, 2020	BUY	$62.1 - $78.08 $299,073 - $376,033	4,816 New	4,816 $304,000
Q1 2020 Apr 09, 2020	SELL	$62.63 - $80.22 $478,367 - $612,720	-7,638 Closed	0 $0
Q4 2019 Jan 13, 2020	BUY	$61.62 - $67.78 $115,106 - $126,613	1,868 Added 32.37%	7,638 $496,000
Q3 2019 Oct 11, 2019	SELL	$62.51 - $69.0 $485,827 - $536,268	-7,772 Reduced 57.39%	5,770 $365,000
Q2 2019 Jul 15, 2019	BUY	$61.87 - $69.38 $130,916 - $146,808	2,116 Added 18.52%	13,542 $914,000
Q1 2019 May 06, 2019	BUY	$62.53 - $70.05 $74,473 - $83,429	1,191 Added 11.64%	11,426 $746,000
Q4 2018 Mar 28, 2019	BUY	$60.54 - $79.0 $619,626 - $808,565	10,235 New	10,235 $644,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kg&L Capital Management,Llc, based on Form 13F filings with the SEC.

Stay updated on Kg&L Capital Management,Llc with notifications on news.